{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "65c7f5b8",
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "\n",
    "import os\n",
    "import boto3\n",
    "\n",
    "S3_BUCKET = os.getenv('S3_BUCKET')\n",
    "s3_client = boto3.client(\n",
    "    's3'\n",
    ")\n",
    "\n",
    "import json\n",
    "from typing import Optional"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "49628934",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_jsonl(path: str, from_s3: Optional[bool] = True):\n",
    "    if from_s3:\n",
    "        if not S3_BUCKET:\n",
    "            raise ValueError('S3_BUCKET env variable is not set.')\n",
    "        resp = s3_client.get_object(Bucket = S3_BUCKET, Key = path)\n",
    "        lines = resp['Body'].read().decode('utf-8').splitlines()\n",
    "        return [json.loads(l) for l in lines if l.strip()]\n",
    "    else:\n",
    "        with open(path, 'r', encoding = 'utf-8') as f:\n",
    "            return [json.loads(l) for l in f if l.strip()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "08598f90",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = load_jsonl('data/processed/processed_chunks.jsonl', from_s3 = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "16cc2da3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'id': 'PMC10443056::chunk_0',\n",
       "  'chunk_index': 0,\n",
       "  'text': \"alzheimer ' s disease ( ad ), the most common form of dementia, is a central neurodegenerative disease characterized by progressive cognitive impairment and memory loss. the main pathological features include intracellular neurofibrillary tangles ( 1 ) and extracellular β - amyloid ( aβ ) peptide aggregation ( 2 ) to form senile plaques. these pathological changes lead to clinical manifestations characterized by memory loss, impairment of abstract thinking, numeracy deficits, and changes in personality and behavior ( 3 ). according to previous studies, the pathogenesis of ad mainly includes the following : abnormal accumulation of aβ ( 4 ), τ - protein hyperphosphorylation ( 5 ), neuroinflammation ( 6 ), cardiocerebral cascade ( 7 ), cholinergic deficiency ( 8 ), excitatory amino acid toxicity ( 9 ). at present, there is no treatment to cure or delay the process of the disease. however, with the increasing number of patients with ad, ad has become one of the main medical and health societal issues. to address the lack of effective drugs and the failure of continuous clinical trials, the current research focus is on therapeutic strategies for inducing the regeneration of neural stem cells ( nscs ). in recent years, research on promoting targeted neural regeneration has received increasing attention. therefore, the current review is focused on the mechanisms of induced nerve regeneration in the treatment of ad. neural regeneration is the process of generating new neurons or restoring neuronal structure, which mainly refers to the proliferation and differentiation of neural progenitor cells, and the synaptic plasticity of neurons against memory disorders and the ageing - related decline of learning and memory ( 10 ). in 1965, altman and das ( 11 ) first demonstrated that new neurons could be generated in the adult mammalian brain. since then, continuous studies have found that nerve regeneration in the brains of adult mammals mainly occurs in two regions, namely\",\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_1',\n",
       "  'chunk_index': 1,\n",
       "  'text': '10 ). in 1965, altman and das ( 11 ) first demonstrated that new neurons could be generated in the adult mammalian brain. since then, continuous studies have found that nerve regeneration in the brains of adult mammals mainly occurs in two regions, namely, the subgranular zone in the dentate gyrus of the hippocampus and the subventricular zone ( 12, 13 ). nerve regeneration may also occur in other brain areas, such as the neocortex ( 14 ) and striatum ( 15 ). however, neurogenesis in these areas seems to occur at lower levels. to explore whether neurogenesis in humans lasts a lifetime, tobin et al ( 16 ) examined the brains of 18 cadaver donors with a mean age of 90. 6 years in 2019. among them, not only proliferating neural precursor cells ( nestin + / pcna + ), undifferentiated neural stem cells ( nestin + sox2 + ) and proliferating neural stem cells ( nestin + / sox2 + / ki67 + ), but also newborn immature neurons [ doublecortin ( dcx ) + / pcna + ], were found in the brains of patients with ad, which indicated that hippocampal neurogenesis persisted in the aged and diseased human brain ( 16 ). in addition, the study found a clear association between the number of newborn immature neurons and the cognitive scores of these donors. the more dcx + / pcna + cells that are produced, the more cognitive performance is improved, suggesting that the number of neurons is positively associated with cognitive function ( 16 ). the level of cognitive function also depends to some extent on the integrity and transmission efficiency of synapses. synapses are the sites where functional connections form between neurons, and they are also the key places for information transmission. synapses are structurally unstable and dynamic, which can mean that they are susceptible to nutrient',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_2',\n",
       "  'chunk_index': 2,\n",
       "  'text': 'and transmission efficiency of synapses. synapses are the sites where functional connections form between neurons, and they are also the key places for information transmission. synapses are structurally unstable and dynamic, which can mean that they are susceptible to nutrient levels such as those affected by brain - derived neurotrophic factor ( bdnf ) and nerve growth factor ( ngf ), diseases such as ad and other factors such as inflammation and oxidative stress. an increasing number of studies have shown that the loss of synapses in the hippocampus and neocortex is an early symptom of ad and one of the main causes of cognitive dysfunction ( 10, 17 ). synaptic damage is one of the most important causes of cognitive decline in ad. therefore, inducing nerve regeneration might fundamentally treat cognitive dysfunction in ad. in recent years, research on nerve regeneration has been extensive, but generally, it has aimed to solve two main issues : how to replenish missing or damaged neurons, and how to re - establish neural connections. in various transgenic ( tg ) rodent models, nerve regeneration ability could be improved by external interventions such as treatment with different types of drugs such as escitalopram, trodusquemine, agomelatine, silibinin, esculentoside a and butyrate ( 18 - 23 ), the transplantation of human nscs ( hnscs ) ( 24, 25 ) and electrical stimulation ( 26 ), which have been proven to increase the number of neuronal precursor cells, and ameliorate the degree of τ - phosphorylation and ad - related memory loss. the effects of different external interventions on inducing nerve regeneration in various tg rodent models in recent years are summarized in table i. new mature neurons induced by external interventions from the migration of existing nscs in certain regions or the generation of nscs can replenish the missing',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_3',\n",
       "  'chunk_index': 3,\n",
       "  'text': \"interventions on inducing nerve regeneration in various tg rodent models in recent years are summarized in table i. new mature neurons induced by external interventions from the migration of existing nscs in certain regions or the generation of nscs can replenish the missing or damaged cells, which contributes to restoring part or even all of the neural network ( 18 - 26 ). in conclusion, cognitive function is closely related to the number of neurons and synaptic integrity. therefore, the recovery of damaged neurons and increase in the number of neurons induced by nerve regeneration is expected to improve cognitive levels, and allow more efficient treatment of ad. among the neurotrophin family factors, bdnf is the most widely distributed in the central nervous system ( cns ). bdnf mainly exists in the hippocampus, cortex and basal forebrain, and plays a key role in synaptic plasticity, neuronal survival, neuronal differentiation and neuronal development ( 27 ). reduced levels of bdnf are associated with different categories of neurological disorders, including neurodegenerative disease, such as ad ( 28 ) and parkinson ' s disease ( 29 ), neurodevelopmental disorders, such as developmental delays ( 30 ), and neurobehavioural and neuropsychiatric disorders ( 31 ), such as depression and anxiety. studies have shown that decreased bdnf levels lead to a lack of neuronal nutritional support, resulting in the degeneration of specific neuronal populations in the basal forebrain cholinergic system in ad ( 32, 33 ). with continuous studies on the role of bdnf, it has been found that bdnf has a physiological effect on the inhibition of neuronal apoptosis and the treatment of cognitive impairment, suggesting that increasing bdnf levels might be a promising target for the treatment of cognitive decline in patients with ad. when\",\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_4',\n",
       "  'chunk_index': 4,\n",
       "  'text': 'bdnf has a physiological effect on the inhibition of neuronal apoptosis and the treatment of cognitive impairment, suggesting that increasing bdnf levels might be a promising target for the treatment of cognitive decline in patients with ad. when bdnf nutrient solution was injected into the medial entorhinal cortex ( 120 µg / side, once a day ) of aged fischer rats with cognitive degeneration, their spatial learning and memory abilities were markedly improved ( 34 ). in addition, invasive gene therapy to overexpress bdnf has been successfully demonstrated to enhance synaptic protein expression and neuronal proliferation, as well as to attenuate amyloid load in app / ps1 transgenic mice ( 35 ). similar conclusions were obtained when the studies were extended to non - human primates. neuronal apoptosis in the endodermis of monkeys was induced with bilateral radiofrequency lesions in the perforant path. the monkeys were then stereotaxically injected with a lentiviral vector expressing bdnf into the entorhinal cortex. stereological quantification revealed that the lesions of the perforant path without bdnf treatment resulted in the loss of 45. 9±8. 5 % of neurons in layer ii of the entorhinal cortex in the lateral region compared with that in intact monkeys. however, the monkeys in which lesions of the perforant path were treated with bdnf were able to maintain 85. 4±7. 1 % of the neurons on the lesion side, and their brains continued to function normally, suggesting that bdnf can also notably prevent neuronal death in non - human primates ( 34 ). there was little correlation between bdnf levels and cognitive decline in patients with a clinical diagnosis of mild cognitive impairment. however, a high level of bdnf expression could effectively slow the rate of',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_5',\n",
       "  'chunk_index': 5,\n",
       "  'text': 'non - human primates ( 34 ). there was little correlation between bdnf levels and cognitive decline in patients with a clinical diagnosis of mild cognitive impairment. however, a high level of bdnf expression could effectively slow the rate of cognitive decline in patients with ad ( 36 ). bdnf affects neuronal plasticity by inducing neurotransmitter release ( 37 ), increasing vesicle docking and enhancing the glutamate - induced postsynaptic response ( 38 ). bdnf binds to the high - affinity tropomyosin - related kinase b ( trkb ) receptor, and then induces trk dimerization and autophosphorylation ( 39 ), thus activating the downstream cascades of the phosphatidylinositol 3 - kinase / protein kinase b ( pi3k / akt ) intracellular signal transduction pathways ( 40 ). akt is phosphorylated through its interaction with pi3k and attaches to the inner surface of the plasma membrane ( 41 ). phosphorylated akt terminates cell apoptosis and induces the survival of nerve cells by inhibiting the activity of the tumour suppressor gene p53 or directly blocking the activity of the apoptosis pathway ( 41 ). under normal conditions, cytochrome c ( cyt - c ) exists in the lacunae between the inner and outer membrane of mitochondria, and the stimulation of apoptotic signals causes the release of cyt - c from the mitochondrial lacunae into the cytoplasm ( 42 ). before the release of cyt - c, phosphorylated ( p ) - akt regulates the activity of bcl - 2 family members and controls the release of cyt - c from the mitochondria into the cytoplasm. after the release of cyt - c, p - ak',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_6',\n",
       "  'chunk_index': 6,\n",
       "  'text': '( p ) - akt regulates the activity of bcl - 2 family members and controls the release of cyt - c from the mitochondria into the cytoplasm. after the release of cyt - c, p - akt can also modulate the components of the apoptosome and inhibit the formation of the apoptosome, thereby blocking the apoptosis pathway mediated by the mitochondria ( 43 ). together, bdnf mediates the activity of the pi3k / akt pathway by binding to the membrane receptor trkb, thereby regulating cell survival and synaptic function, and making the bdnf / trkb / pi3k / akt signalling pathway a potential therapeutic target for neurodegeneration ( 44 ). furthermore, the bdnf protein is a charged, yet net hydrophobic molecule with a low molecular weight, causing it to have a short half - life ( t1 / 2 ) in humans, which makes it a non - ideal biological drug candidate ( 45 ). previous studies have shown that zinc finger e - box - binding homeobox 85, a potent and full agonist of human trkb, plays a role in neuroprotection and neurorestoration ( 45, 46 ). 7, 8 - dihydroxyflavone ( 7, 8 - dhf ), a potent trkb agonist, has also been shown to have therapeutic effects on ad ( 47 ). in addition, it has been demonstrated that lmds - 1, another agonist of trkb, can improve the pathological phenotype of early ad mice by upregulating the expression of bdnf. moreover, lmds - 1 is more effective than 7, 8 - dhf in alleviating the behaviour and pathological characteristics of mice with ad ( 48 ). in conclusion, previous studies have found',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_7',\n",
       "  'chunk_index': 7,\n",
       "  'text': 'the expression of bdnf. moreover, lmds - 1 is more effective than 7, 8 - dhf in alleviating the behaviour and pathological characteristics of mice with ad ( 48 ). in conclusion, previous studies have found that the expression level of bdnf is positively correlated with the cognitive level in rats, non - human primates and humans. bdnf mainly regulates the survival of nerve cells and synaptic plasticity by triggering the bdnf / trkb / pi3k / akt signalling pathway, and ultimately improves cognitive ability. in addition, other trkb agonists play a functional role in neuroprotection and cognitive function, similar to bdnf. ngf is one of the earliest discovered and most well - studied nerve cell growth regulators among neurotrophic factors ; it has dual biological functions of nourishing and promoting neurite growth of neurons ( 49 ). ngf also plays an important role in the development, differentiation, growth, regeneration and function of central and peripheral neurons ( 50 ). recent studies have shown that mice lacking ngf exhibit deposits of aβ plaques, τ - hyperphosphorylation, synaptic dysfunction and other typical pathological features of ad ( 51, 52 ). treatment targeting ngf not only reduces pathological changes in ad but also contributes to the survival and axonal regeneration of injured neurons in ad ( 53 ). the knockout of the ngf gene resulted in a 55 % reduction in basal forebrain cholinergic neurons and a 62 % reduction in hippocampal cholinergic neurons in the cns of adult mice, suggesting that ngf deficiency may be an important factor in neuron loss ( 54 ). increasing ngf may be an effective strategy to reduce aβ deposition and improve clinical cognitive impairment in ad. in the brain, ngf is tonically secreted in its precursor form, prongf',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_8',\n",
       "  'chunk_index': 8,\n",
       "  'text': 'important factor in neuron loss ( 54 ). increasing ngf may be an effective strategy to reduce aβ deposition and improve clinical cognitive impairment in ad. in the brain, ngf is tonically secreted in its precursor form, prongf, which is then cleaved by the extracellular protease into mature ngf ( mngf ) ( 55 ). interfering with ngf transport or reducing ngf processing may lead to the overexpression and abnormal accumulation of prongf and a deficiency of mngf. mngf is required for the growth and plasticity of cholinergic neurons ( 56 ). ngf bioactivity is mediated by binding to the high - affinity trka receptor and the low - affinity tumour necrosis factor neurotrophin receptor ( p75ntr ) on the plasma membrane ( 57 ). ngf produced by hippocampal and cortical neurons binds to trka and p75ntr, and then forms dimeric complexes that maintain the normal activity of neurons, suggesting that ngf maintains the normal function of neurons through the trka / p75ntr - mediated signalling pathway ( 58 ). in the absence of trka, a combination of ngf and p75ntr accelerates apoptosis by activating p53, ceramide and c - jun n - terminal kinase pathways ( 59 ). it was found that the prongf level in the parietal cortex of patients with ad was twice as high as that of healthy subjects, suggesting that the degeneration of cholinergic neurons in patients with ad may be associated with a deficiency of mngf ( 60 ). after treatment with ngf, the activity of choline acetyltransferase ( chat ) in the cerebrospinal fluid of patients with ad is markedly enhanced, while the activity of chat in the cerebrospinal fluid is associated with cognitive function, suggesting that ngf may',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_9',\n",
       "  'chunk_index': 9,\n",
       "  'text': 'acetyltransferase ( chat ) in the cerebrospinal fluid of patients with ad is markedly enhanced, while the activity of chat in the cerebrospinal fluid is associated with cognitive function, suggesting that ngf may improve cognitive function by mediating chat activity ( 60 ). at present, there are animal experiments and clinical trials of ngf with different infusion modes, including direct intracerebral infusion of ngf ( 61 ), peripheral administration of ngf using nasal ( 62 ) or intraocular ( 63 ) delivery and ngf delivery using viral vectors ( 53, 64 ). although these methods have been proven to be effective, there are drawbacks such as pain, weight loss and difficulty controlling the dose. it has been found that the sustained release of ngf can be induced by redirected implantation of ngf into the basal forebrain through encapsulated cell biodelivery of ngf ( ngf - ecb ), in which the encapsulated cells are made from fibroblasts ( 65 ). in addition, elevated ngf can regulate the exocytosis of presynaptic terminal vesicles and induce bfcn electrochemical signalling, suggesting that high levels of ngf may alter ad - related synaptic failure and neurotransmission defects ( 66 ). ngf - ecb implantation in patients with mild to moderate ad can obviously repair the degeneration of bfcn, and reduce the rate of brain atrophy and cognitive decline ; importantly, the safety of the treatment has been demonstrated ( 67 ). furthermore, the long - term release of ngf by implanted transmitters would need to be optimized to achieve a more predictable and stable effect in the treatment of ad. in addition, agonists of trka neurotrophin receptors such as doxycycline ( 68 ) or ngf - mimicking drugs',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_10',\n",
       "  'chunk_index': 10,\n",
       "  'text': \"be optimized to achieve a more predictable and stable effect in the treatment of ad. in addition, agonists of trka neurotrophin receptors such as doxycycline ( 68 ) or ngf - mimicking drugs such as lm11a - 31 ( 69 ) were reported to have ngf - like effects. in conclusion, ngf is closely related to the proliferation, differentiation, regeneration and electrophysiological function of central and peripheral neurons. interference with ngf transport or processing may impair the normal function of neurons. in the ad brain, targeted drug therapy or gene therapy can induce the release of mngf or increase the expression level of ngf, and then ngf activates the ngf - trka signalling pathway in neurons, which can ameliorate the issues of synaptic failure and neurotransmission defects, and ultimately improve the cognitive level of patients with ad. as the ‘ cholinergic hypothesis of alzheimer ' s disease ’ was proposed by bartus et al ( 70 ) in 1982, cholinergic deficiency was accepted as one of the early pathogenesis factors of ad. according to this theory, a deficiency of acetylcholine ( ach ), a neurotransmitter in the synapses of neurons, is considered to be a key factor leading to cognitive dysfunction in patients with ad. ach and ach esterase ( ache ) are two major elements in the cholinergic nervous system. ache is a key enzyme in the hydrolysis of ach. both ach and ache are widely distributed in the cns, and are necessary for learning and memory formation ( 71 ). at present, there are four types of ache inhibitors ( acheis ) that are most widely used for the clinical treatment of ad, including donepezil, tacrine, rivastigmine and galanthamine ( 72 ). although all of these drugs can inhibit the\",\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_11',\n",
       "  'chunk_index': 11,\n",
       "  'text': 'ache inhibitors ( acheis ) that are most widely used for the clinical treatment of ad, including donepezil, tacrine, rivastigmine and galanthamine ( 72 ). although all of these drugs can inhibit the activity of ache, they work by different mechanisms. donepezil is a specific and reversible achei. rivastigmine is a pseudoirreversible achei. galanthamine is a selective, reversible achei. tacrine is a non - competitive and reversible achei that was withdrawn in 2013 due to its hepatotoxicity ( 73 ). the effects of these drugs are different ; donepezil is more active than tacrine, whereas donepezil is safe and reliable, and the first choice for the treatment of patients with mild to moderate ad, as it has fewer side effects such as nausea, vomiting, diarrhea and dizziness ( 74 ). the effectiveness of galantamine is superior to that of rivastigmine, and is second only to that of donepezil ( 75 ). rivastigmine is a relatively effective drug for patients with advanced - stage ad ( 74 ). clinical studies have shown that these drugs can not only delay the onset of dementia in patients with ad, but also improve mental behaviour and the ability to carry out daily living activities ( 75, 76 ). in the pathological process of ad, the activity of ache in the brain is notably increased, which leads to the hydrolysis of ach and the loss of cholinergic neurons. moreover, the high levels of glutamate in the synaptic cleft of neurons activate the n - methyl - d - aspartic acid receptor, which opens ca2 + channels and increases ca2 + influx, leading to neuronal necrosis ( 77 ). most acheis inhibit ache activity and reduce the decomposition of',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_12',\n",
       "  'chunk_index': 12,\n",
       "  'text': 'neurons activate the n - methyl - d - aspartic acid receptor, which opens ca2 + channels and increases ca2 + influx, leading to neuronal necrosis ( 77 ). most acheis inhibit ache activity and reduce the decomposition of ach, which effectively protects neuronal survival and alleviates ad symptoms ( 78, 79 ). donepezil can also protect neurons from glutamate - induced neurotoxicity by directly or indirectly activating nicotinic ach receptors ( nachrs ). the combination of nachr antagonists and donepezil markedly reduced the neuroprotective effects of donepezil, suggesting that donepezil exerts neuroprotective effects in foetal sprague - dawley rats by binding to nachrs ( 80 ). donepezil can also prevent aβ - induced neural cell death by activating the pi3k pathway ( 80 ). the activation of nachrs can trigger downstream pi3k and thereby catalyse the production of p - akt, which enhances the activation of the pi3k pathway ( 81 ). in addition, it was found that the phosphorylation levels of akt were notably increased in astrocytes after treatment with donepezil ( 10 mm ) for 6 h ( 82 ). the therapeutic effect of donepezil was alleviated when donepezil was used in combination with a pi3k inhibitor ( 30 mm ) or an akt inhibitor ( 1 mm ), suggesting that donepezil plays a neuroprotective role in the brain through the pi3k / akt signalling pathway ( 82 ). in summary, donepezil plays a neuroprotective role by either inhibiting ache or activating nachrs and their downstream pi3k / akt pathway. it has also been shown that the neuroprotective effect',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_13',\n",
       "  'chunk_index': 13,\n",
       "  'text': 'in summary, donepezil plays a neuroprotective role by either inhibiting ache or activating nachrs and their downstream pi3k / akt pathway. it has also been shown that the neuroprotective effect of achei drugs is achieved by engaging in the upregulation of the antiapoptotic bcl - 2 protein. when acheis are combined with ha14 - 1, a drug that inhibits bcl - 2, the neuroprotective effect of acheis is weakened, suggesting that acheis exert neuroprotective effects by upregulating the target gene bcl - 2 ( 83 ). the different concentrations of acheis have various degrees of effectiveness in preventing apoptosis. galantamine, donepezil and rivastigmine show the highest neuroprotective effects at 0. 3, 1 and 3 m, respectively. with the increase in concentration, galantamine and donepezil exhibit a well - characterized u - shaped neuroprotective curve with the percentage of cell death in longitudinal coordinates. high concentrations of galantamine block nachrs, and lead to the absence of neuroprotective effects on cell death caused by aβ in the human neuroblastoma sh - sy5y cell line ( 83 ). in conclusion, achei drugs have been widely used in the clinical treatment of ad. one main capability of achei drugs is to reduce the decomposition of ach by inhibiting ache, and the other is to activate nachrs and improve glutamate transport, thereby activating the pi3k / akt pathway and upregulating the downstream target protein bcl - 2. therefore, achei drugs induce the survival of nerve cells, enhance the connection between synapses and eventually attenuate ad symptoms. histone acetylation is an epigenetic modification that alters gene expression',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_14',\n",
       "  'chunk_index': 14,\n",
       "  'text': 'target protein bcl - 2. therefore, achei drugs induce the survival of nerve cells, enhance the connection between synapses and eventually attenuate ad symptoms. histone acetylation is an epigenetic modification that alters gene expression without changing the dna sequence. hdacs catalyze not only histone deacetylation, but also a variety of non - histone protein deacetylations, maintaining the dynamic equilibrium between acetylation and deacetylation, and regulating gene expression ( 84 ). the hdac family, composed of 18 isoforms, is divided into five groups on the basis of phylogenetic characteristics : class i ( hdac1, hdac2, hdac3 and hdac8 ), class iia ( hdac4, hdac5, hdac7 and hdac9 ), class iib ( hdac6 and hdac10 ), class iii ( silent information regulator 2 ) and class iv ( hdac11 ). the function of hdacs is to deacetylate the lysines on histone tails, causing the condensation and subsequent repression of chromatin ( 85 ). hdacs are involved in chromatin remodelling, gene expression, and synaptic formation and plasticity, and have been used as targets for improving synaptic function ( 86 ). the degree of histone deacetylation is closely related to the pathological phenotype of ad. high levels of hdac ( hdac6 ) expression can be seen in the hippocampus and the cortex of patients with ad ( 87 ). hdac1 plays a role in neurodegeneration, hdac2 participates in modulating synaptic plasticity and long - lasting changes in neural circuits, and hdac3 - 11 and class iii hdacs are beneficial for their neuroprotective effects ( 88 ). the loss of hdac',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_15',\n",
       "  'chunk_index': 15,\n",
       "  'text': '##2 participates in modulating synaptic plasticity and long - lasting changes in neural circuits, and hdac3 - 11 and class iii hdacs are beneficial for their neuroprotective effects ( 88 ). the loss of hdac1 in neurons causes dna damage and cell death, while the lack of hdac2 in mice improves learning and memory, enhances synaptic plasticity, and increases dendritic spine density and synapse number ( 89 ). rgfp - 966, a selective hdac3 inhibitor, can increase h3 and h4 acetylation and bdnf acetylation, resulting in increased bdnf expression, reduced τ and aβ1 - 42 accumulation, and improved spatial learning and memory in 3xtg - ad mice ( 90 ). in a previous study, a notable increase in hdac4 expression was responsible for neurotoxic aβ deposition in neuronal cells in a dose - dependent manner ( 91 ). tasquinimod, a selective hdac4 inhibitor, can partly rescue the expression of genes related to synaptic plasticity and neuronal memory, and shows the effect of an hdac4 - targeting treatment ( 92 ). owing to a notable increase in hdac6 expression in the hippocampus and cortex of patients with ad and ad animal models, hdac6 inhibitors are being investigated for the treatment of ad ( 93 ). moreover, a phosphodiesterase type 5 ( pde5 ) inhibitor was shown to markedly activate camp / cgmp responsive element binding, which improved the long - term potentiation mechanism following hippocampal damage in amyloid β precursor ( app ) / presenilin - 1 ( ps1 ) mice. the synergistic effect of pde5 inhibitors and hdac enzyme ( class i hdacs and hdac6 ) inhibitors can be more effective in the treatment of',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_16',\n",
       "  'chunk_index': 16,\n",
       "  'text': 'app ) / presenilin - 1 ( ps1 ) mice. the synergistic effect of pde5 inhibitors and hdac enzyme ( class i hdacs and hdac6 ) inhibitors can be more effective in the treatment of ad, which has proven to be a potential new therapeutic approach ( 93 ). cm - 414, a dual inhibitor of pde5 and hdacs, not only reduced the levels of aβ and p - τ in the brain, but also increased the density of dendritic spines in hippocampal neurons and alleviated cognitive deficits in tg2576 mice ( 93 ). furthermore, 44b, another dual compound inhibitor of pde5 and hdacs, markedly reduced the level of happ by 55 % and the level of p - τ proteins by 30 % in vitro, suggesting that 44b directly inhibited happ and p - τ production ( 94 ). in addition, an in vivo study showed that 2 weeks of treatment with the dual compound inhibitor 44b ( 40 mg / kg ) could recover partial memory impairment in elderly ( 16 - month - old ) tg2576 mice ( 94 ). in conclusion, hdacs are involved in synaptogenesis and cognitive function by increasing deacetylation modifications of histones or genes associated with memory such as bdnf. the synergistic effect of pde5 and hdac enzyme inhibitors can not only induce the acetylation of histones and synapse - related genes, but also inhibit the levels of aβ and p - τ, which has a better therapeutic effect on ad. in recent years, physical intervention in the treatment of ad has gradually received widespread attention. using physical intervention to induce neurogenesis is expected to be an effective therapeutic treatment for ad. currently, there are two major and reliable non - traumatic brain stimulations used in the clinic, namely, repetitive transcranial magnetic stimulation (',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_17',\n",
       "  'chunk_index': 17,\n",
       "  'text': 'widespread attention. using physical intervention to induce neurogenesis is expected to be an effective therapeutic treatment for ad. currently, there are two major and reliable non - traumatic brain stimulations used in the clinic, namely, repetitive transcranial magnetic stimulation ( rtms ) and transcranial direct current stimulation ( tdcs ). tms refers to the process of stimulating cortical neurons with electromagnetic fields and then activating neuronal circuits in the cns ( 95 ), which can recover the function of synaptic transmission in the cerebral cortex, and is considered a non - invasive and painless treatment technology ( 96 ). rtms is the continuous administration of repetitive electromagnetic stimulation to reduce the imbalance between excitatory and inhibitory signals, thereby mediating synaptic activity and neuroplasticity ( 97 ). previous studies showed that rtms markedly promoted the cognitive level and language ability of patients with ad, especially patients with mild ad, indicating that treatment with rtms could effectively improve the clinical manifestations of ad ( 98, 99 ). research suggests that rtms has positive therapeutic effects on the nerves and psychology of patients, as assessed by a neuropsychological quantitative scale such as the world health organization - university of california auditory word learning test ( who - uclaavlt ) ( 98 ), ad assessment scale - cognitive section ( adas - cog ) ( 99 ), mini - mental state examination ( mmse ) ( 100 ) and montreal cognitive assessment scale ( moca ) ( 99 ). these results suggest that rtms improved the cognitive ability and mental behaviour of patients with mild to moderate ad. however, variations in the intensity and location of rtms lead to different therapeutic effects. a randomized controlled trial showed that high - frequency rtms ( 20 hz ) markedly improved cognitive impairment, while low - frequency rtms ( 1 hz ) had no obvious effect in patients with mild to moderate ad ( 101 ). moreover, studyhas proven that the',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_18',\n",
       "  'chunk_index': 18,\n",
       "  'text': 'controlled trial showed that high - frequency rtms ( 20 hz ) markedly improved cognitive impairment, while low - frequency rtms ( 1 hz ) had no obvious effect in patients with mild to moderate ad ( 101 ). moreover, studyhas proven that the cognitive function of patients selectively deteriorates after 10 min of low - frequency rtms ( 1 hz ) ( 102 ). these results suggested that only high - frequency rtms has a positive effect on ameliorating cognitive impairment. research on different stimulus locations found that there was a notable improvement in the cognition and memory of patients with mild or moderate ad who received rtms in the right or bilateral dorsolateral prefrontal cortex ( dlpfc ), but not in those who received rtms in the left dlpfc ( 103 ). tdcs is the direct use of a weak electrical current ( usually 1 - 2 ma ) to stimulate specific areas of the brain, leading to a change in resting membrane potential in neurons, and thus inducing the excitability of brain cells. the excitability of neurons was increased by the depolarization of anodic current stimulation and decreased by the hyperpolarization of cathodic current stimulation ( 104 ). the level of γ - aminobutyric acid in the motor cortex decreased after anodic current stimulation, whereas there was no change in the γ - aminobutyric acid level in the motor cortex with cathodic current or sham stimulation, suggesting that anodic current stimulation might elicit neuronal excitation by inhibiting the level of γ - aminobutyric acid ( 105 ). the experimental results showed that the expression of bdnf mrna induced by tdcs was 9. 5 times higher than that of the control group, suggesting that tdcs might be conducive to brain health by enhancing the level of bdnf ( 106 ). clinical experimental results showed that visual recognition memory scores had increased by 8',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_19',\n",
       "  'chunk_index': 19,\n",
       "  'text': '. 5 times higher than that of the control group, suggesting that tdcs might be conducive to brain health by enhancing the level of bdnf ( 106 ). clinical experimental results showed that visual recognition memory scores had increased by 8. 9 % when the temporal cortex of patients with ad was stimulated by tdcs for 30 min for 5 days, but these beneficial effects lasted only 1 month after the end of stimulation regimens ( 107 ). although increasing the strength of an electric current might lead to excitatory changes in a larger area of the cortex, the highest strength clinically used is 2 ma for safety purposes. the findings of another study have suggested that increasing the strength of tdcs did not necessarily improve the curative effect, as tdcs enhanced electrical signals only in the existing neural network and did not stimulate action potentials from the resting state of neurons ( 108 ). the therapeutic effect of tdcs depends on the current physiological state of the brain, and even increasing the intensity of electrical current cannot form a new neural network in the brain ( 109 ). therefore, these results suggest that the therapeutic effect of tdcs might be limited in patients with advanced ad, who have a reduction in both synaptic plasticity and long - term potentiation. although both rtms and tdcs can improve the cognitive function of patients with ad to a certain extent, they also have limitations. first, the electric current only reaches the cerebral cortex, and it is difficult for the current to reach the medial prefrontal cortex, insula, cingulate gyrus and other deep brain regions. second, repeated use of rtms may also induce epilepsy ; therefore, rtms is potentially harmful to the human body ( 110 ). rtms stimulates a wide range of brain areas, and therefore lacks specificity and accuracy. previously, light therapy has been gradually favoured by clinicians due to its fewer side effects and deep treatment area. studies have shown that 1,',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_20',\n",
       "  'chunk_index': 20,\n",
       "  'text': '110 ). rtms stimulates a wide range of brain areas, and therefore lacks specificity and accuracy. previously, light therapy has been gradually favoured by clinicians due to its fewer side effects and deep treatment area. studies have shown that 1, 072 - nm near - infrared ( nir ) light can protect immune cells by limiting the toxic effects of ultraviolet - a on them, and prevents cell apoptosis ( 111 ). after 1, 072 - nm nir light treatment, the expression of heat shock proteins was markedly increased, and the levels of aβ and p - τ protein were notably decreased ( 112 ). furthermore, other wavelengths of light in the range from red to infrared light have also been shown to improve ad symptoms ( 113, 114 ). iaccarino et al ( 110 ) found that the treatment of ad mice with a 40 - hz light - emitting diode could enhance γ brainwaves and reduce aβ deposition in the brain ; however, the benefit lasted for only 1 week once therapy was discontinued. in addition, intermittent flickering light therapy shows much promise for mild cognitive impairment and patients with mild ad who suffer from both sleep disturbances and cognitive deficits, including memory loss, mental behavior abnormalities and a reduced ability to perform daily tasks ( 115 ). the aforementioned study showed that a 40 - hz flicker can not only increase γ brainwaves in the visual cortex, decrease aβ deposition, and reduce both app and p - tau protein expression in the hippocampus, but that it can also have a positive impact on the circadian rhythms of patients with ad. in summary, as physical therapies for ad, rtms and tdcs can improve the cognitive function of patients with ad by activating the synaptic activity of neuronal circuits in the cns. however, the treatment effects of those electrical stimulations are transient, and the stimulations have numerous side effects. light therapy has gradually attracted the interest of researchers. research',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_21',\n",
       "  'chunk_index': 21,\n",
       "  'text': \"activating the synaptic activity of neuronal circuits in the cns. however, the treatment effects of those electrical stimulations are transient, and the stimulations have numerous side effects. light therapy has gradually attracted the interest of researchers. research suggests that infrared light and wavelengths in the range from red to infrared light are effective in the treatment of ad with the advantage of having few side effects. nerve damage and insufficient endogenous nerve regeneration in the brains of patients with ad lead to neuronal depletion and the disruption of neural circuits, ultimately causing cognitive decline ( 116 ). although the induction of nerve regeneration has been proven to fundamentally solve the issue of neuronal loss in ad, the number of endogenous nscs in the adult brain is limited ; therefore, it is anticipated that nsc transplantation will induce nerve regeneration ( 117 ). stem cell therapy emerged in the early 2000s and has been explored as a potential treatment for various diseases, especially neurological diseases, including ad, parkinson ' s disease, huntington ' s disease, multiple sclerosis and stroke ( 118 ). in recent years, successes in the culture and transplantation of nscs have provided a new vision for brain injury repair and ad treatment ( 119 ). nscs have the characteristics of self - renewal and multidirectional differentiation potential ( 120 ). therefore, after nscs are implanted into the brain, surviving nscs migrate and differentiate into neurons and glial cells. newborn neurons integrate into functional neural circuits, which can alleviate learning and memory disorders ( 121 ). exogenous nscs are mainly derived from three sources : direct extraction from embryonic or foetal nerve tissue ( 122 ), transdifferentiation of induced multipotent stem cells ( ipscs ) ( 123 ) and the differentiation of mesenchymal stem cells ( mscs ) ( 124 ). some issues are encountered after the transplantation of nscs extracted from embryonic or foetal nerve\",\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_22',\n",
       "  'chunk_index': 22,\n",
       "  'text': 'multipotent stem cells ( ipscs ) ( 123 ) and the differentiation of mesenchymal stem cells ( mscs ) ( 124 ). some issues are encountered after the transplantation of nscs extracted from embryonic or foetal nerve tissue, such as immune rejection and teratomas, and these problems, along with various ethical issues, limit the application of these nscs in vivo. ipscs are induced by the transduction of four reprogramming factors, qct3 / 4, sox2, klf4 and c - myc, in the dermal fibroblasts of the patient ( 125 ). nscs originating from ipscs lack ethical and histocompatibility problems, but there are still issues such as a low induction rate and the risk of triggering tumours ( 126 ). mscs are derived from bone marrow, umbilical cord, foetal blood and adipose tissue. mscs have the ability to differentiate into different tissue types and cells, such as nerve cells, osteocytes and cardiomyocytes. the advantages of mscs are their wide range of sources, easy isolation and culture, and lack of ethical issues and immune rejection, but they also have issues such as difficulty differentiating into functional neurons in vivo ( 127 ). a large number of studies have confirmed that the transplantation of exogenous nscs can induce nerve regeneration ( 128 - 130 ), but the mechanism is not fully understood. studies have found that exogenous nscs transplanted into the brain not only have the role of replacing lost and injured neurons, but also have the auxiliary role of secreting neurotrophic factors to improve nerve regeneration and immunity ( 131, 132 ). secreted neurotrophins play important roles in the proliferation, survival, migration and differentiation of nscs, thereby participating in neuroprotective and repair functions ( 132 ). however, there are still existing issues with the low',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_23',\n",
       "  'chunk_index': 23,\n",
       "  'text': '). secreted neurotrophins play important roles in the proliferation, survival, migration and differentiation of nscs, thereby participating in neuroprotective and repair functions ( 132 ). however, there are still existing issues with the low survival rate and neuronal differentiation rate of transplanted nscs due to the harsh environment in the brain ( 133 ). both bdnf and ngf are conducive to neuroprotection and the differentiation of endogenous or exogenous nscs into neurons. therefore, a combined method of bdnf and nscs or ngf and nscs for the treatment of ad has been explored. intracerebral injection is not ideal for this combined method due to the short half - life of bdnf and ngf. therefore, a nano - delivery system of bdnf or ngf encapsulated by liposomes, polymer micelles or nanoparticles could be used to establish a long - term, continuous, slow - release and controlled drug delivery mode. although some results have been obtained with this system, it is still in the animal phase of research testing, and a clinical application is thus lacking ( 134, 135 ). there is a double therapeutic effect for gene therapy using nscs as a carrier. exogenous genes for bdnf or ngf are transfected into nscs, and bdnf and ngf are thus continuously overexpressed with the proliferation of nscs. on the one hand, bdnf and ngf are widely expressed during cell migration. on the other hand, the expression of bdnf and ngf contributes to promoting the differentiation of nscs into neurons ( 136, 137 ). exosomes ( exos ) are one of the smallest extracellular vesicles released by cells. transplanted exogenous mscs can secrete exos to regulate the pathological microen',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_24',\n",
       "  'chunk_index': 24,\n",
       "  'text': 'nscs into neurons ( 136, 137 ). exosomes ( exos ) are one of the smallest extracellular vesicles released by cells. transplanted exogenous mscs can secrete exos to regulate the pathological microenvironment and neural plasticity, indicating that exos are involved in nerve repair and regeneration ( 138 ). the aforementioned study found that nscs derived from human ipscs secreted exos, which could reduce the inflammatory response, ameliorate oxidative stress and facilitate nsc differentiation, suggesting that nsc - derived exos could be used as a supportive adjuvant for nsc transplantation ( 139 ). another study found that induced neural progenitor cells ( inpcs ) from mouse fibroblasts and astrocytes abundantly released exos, which could promote the proliferation of neural progenitors and release of growth factors via activating the downstream extracellular signal - regulated kinase pathways, indicating that inpc - derived exos played a critical role in functional rehabilitation of brain lesions ( 140 ). moreover, the combination of exogenous nscs with induced exos could alleviate the injury of brain tissue, and promote the recovery of motor function, suggesting that nscs together with exos have potent therapeutic effects in neurological disorders ( 139 ). furthermore, the involvement of micrornas ( mirnas / mir ) in biological activities, including cell growth and metabolism, has been well documented. exos have been used as novel biological vehicles to transfer different mirnas, and the delivery of exo - mediated mirnas had an effect on treating neurological diseases ( 141 ). mir - 21a is enriched in exos at high levels, and has key roles in the generation of neurons and mediating the neurogenic potential of exos ( 138 ). a one study demonstrated that exos with mir - 21a overexpression had a greater capacity for the promotion of neuronal differentiation and the inhibition',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_25',\n",
       "  'chunk_index': 25,\n",
       "  'text': 'the generation of neurons and mediating the neurogenic potential of exos ( 138 ). a one study demonstrated that exos with mir - 21a overexpression had a greater capacity for the promotion of neuronal differentiation and the inhibition of gliogenesis, indicating that exos may achieve a therapeutic effect in neurogenesis promotion via the transference of mir - 21a ( 138 ). mir - 455 - 3p was found to have protective effects on the regulation of app, levels of amyloid - β, mitochondrial biogenesis and dynamics, synaptic activity and the viability or apoptosis of the cell ( 142 ). exos released from mscs alleviated hippocampal neuronal injury through transferring mir - 455 - 3p ( 143 ). injecting mir - 133b exos preserved neurons and promoted the regeneration of axons ( 144 ), and exos harvested from mir - 133b - overexpressing mscs were shown to improve neural plasticity and functional recovery ( 145 ), suggesting that the transfer of exo - mediated mir - 133b represents a novel therapeutic approach for the treatment of neurological diseases. an animal study indicated that transplantation of nscs could protect basal forebrain cholinergic neurons and restore synaptic impairment, eventually leading to improvements in learning and memory functions in app / ps1 tg mice ( 146 ). stem cell therapy for human subjects with ad has been conducted since 2011. in a phase i clinical trial in korea, 9 patients with mild to moderate ad were studied to assess the safety and dose - limiting toxicity of a stereotactic brain injection of human umbilical cord blood - derived mscs ( 147 ). there were no serious adverse events, such as fever, during the follow - up period of 24 months ( 147 ). despite this lack of adverse events, the feasibility and safety of stem cell therapy need to be evaluated further in larger trials. in conclusion,',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_26',\n",
       "  'chunk_index': 26,\n",
       "  'text': 'were no serious adverse events, such as fever, during the follow - up period of 24 months ( 147 ). despite this lack of adverse events, the feasibility and safety of stem cell therapy need to be evaluated further in larger trials. in conclusion, transplanted nscs can not only directly replenish lost neurons, but also indirectly ameliorate the pathological environment by secreting neurotrophic factors or exos, which affect the survival, proliferation, differentiation and synaptic density of neurons. treatment with bdnf combined with nscs or ngf combined with nscs has been proven to efficiently induce nerve regeneration, the level of which is better than that with nsc transplantation alone. however, in clinical applications, issues with brain mechanical injury, graft location, efficacy and safety are still encountered in nsc transplantation. according to the world alzheimer report 2021 ( 148 ), the total estimated annual worldwide cost of dementia is ≥1. 3 trillion us dollars, and the figure is forecast to rise to 2. 8 trillion us dollars by 2030. there is no efficacious drug that can halt ad progression. the high cost and limited efficacy of ad treatment have caused a burden on numerous patients with ad and their families. therefore, it is necessary to find an effective and low - cost therapeutic strategy. inducing neuronal regeneration could improve synaptic plasticity and functional recovery in patients with ad. there are various external interventions that accelerate nerve regeneration, and they have been proven to alleviate the pathological symptoms and memory disorders of ad to a certain extent, but there are still issues to be solved. although nerve regeneration was first proven to exist in the mammalian cns in the 1960s ( 11 ), the enhancement of nerve regeneration as a treatment strategy for ad has been gaining traction only in recent years. a growing number of studies have shown that inducing nerve regeneration can fundamentally improve the self - care ability and cognitive impairment of patients with ad ( 103, 107',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC10443056::chunk_27',\n",
       "  'chunk_index': 27,\n",
       "  'text': 'the enhancement of nerve regeneration as a treatment strategy for ad has been gaining traction only in recent years. a growing number of studies have shown that inducing nerve regeneration can fundamentally improve the self - care ability and cognitive impairment of patients with ad ( 103, 107 ). however, inducing nerve generation is still a difficult, yet key point of intervention methods in the clinical treatment of diseases. previous research in ad has shown that endogenous nerve regeneration can be improved by increasing the expression levels of bdnf and ngf, inhibiting ache, activating nachrs, increasing acetylation modifications of histone and memory - related genes such as bdnf, increasing the synaptic activity of neuronal circuits by electrical stimulation, and transplanting exogenous nscs. currently, there is no clear conclusion on the therapeutic effect of different interventions due to the lack of comparison and rating scale evaluations. moreover, the conclusions on interventions are mostly based on the results of animal experiments, and the clinical therapeutic effects need to be further confirmed. furthermore, physical therapies such as rtms, tdcs and light therapy show a curative effect, but also have side effects on the human body, and the optimal stimulation intensity and duration need to be further investigated. therefore, further studies are needed to determine the effectiveness of different interventions and elucidate the mechanisms for interventions inducing nerve regeneration. in addition, the combination of interventions with different modes of action, such as chemical stimulation and physical stimulation, may be a more robust and effective treatment plan.',\n",
       "  'title': \"Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2023-8-01',\n",
       "  'doi': '10.3892/etm.2023.12143'},\n",
       " {'id': 'PMC9747195::chunk_0',\n",
       "  'chunk_index': 0,\n",
       "  'text': \"alzheimer ' s disease ( ad ) is a complex disorder characterized by the gradual loss of memory and the self - sufficiency of patients, the deterioration of thinking, and of the usage and understanding of written and spoken language, social isolation. it is also associated with behavioral changes, due to a confused state accompanied by apathy, depression and aggression ( 1 - 6 ). this disease occurs mainly in individuals > 60 years of age ; however, there is an increasing prevalence of the disorder in ~ 40 % of the population 2, 000 mirnas have been identified in the human genome that play a key role in critical biological processes ( 37 ), such as development, apoptosis, signal transduction and proliferation. with respect to the brain, they are expressed in neurons and are involved in processes of neuronal differentiation, synaptogenesis and plasticity ( 38 ). according to the literature, mirnas have a significant impact on the development of several neurological diseases and disorders, such as ad, parkinson ' s disease, amyotrophic lateral sclerosis and huntington ' s disease ( 39, 40 ). as regards ad, mirnas have been shown to be involved in aβ pathology by regulating app expression and other enzymes involved in aβ processing, such as β - secretase ( bace1 ). the first study to record the regulatory role of mirnas in app mrna involved the homologous app gene in c. elegans, apl - 1, which showed its developmental regulation by mirna let - 7 ( 41 ). subsequent studies have demonstrated that app is regulated by mirna in humans, where the overexpression of mir - 106a and mir - 520c has been shown to lead to the translational suppression of app mrna, thereby significantly reducing app levels ( 42 ). in addition, mir - 20a, mir - 19, mir - 106b, the mir - 20a family ( 43, 44 ) and mir - 101 (\",\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_1',\n",
       "  'chunk_index': 1,\n",
       "  'text': 'the translational suppression of app mrna, thereby significantly reducing app levels ( 42 ). in addition, mir - 20a, mir - 19, mir - 106b, the mir - 20a family ( 43, 44 ) and mir - 101 ( 45 ) have been shown to directly regulate app mrna in human cells in vitro. in addition, the effect of snps on mirna binding sites in the 3 ′ - utr of app mrna in ad pathology and the risk of ad are demonstrated, where more specifically, mir - 147 and mir - 20a were shown to be the affected snps variants associated with ad in the 3 ′ - utr of app mrna ( 46, 47 ). finally, mirnas, such as mir - 124, which regulates the expression of the polypyrimidine tract - binding protein 1 ( ptb1 ) in neuronal cell lines, have also been implicated in the regulation of the alternative splicing of app ( 48 - 50 ). in general, there is significant evidence of the increased levels of exon 7 and 8 isoforms of app in brains of patients with ad, while abnormal app splicing has been shown to be associated with an increased aβ production ( 51, 52 ). the importance of bace1 activity in ad lies in the fact that this factor cleaves app as the first and rate - limiting step in the formation of aβ ( 53 ). in this case, mirnas belonging to the mir - 29 family have been well - studied in vitro and in vivo. the three major mature mirnas in this family are mir - 29a, mir - 29b and mir - 29c, the latter of which has been shown to regulate bace1 expression by targeting the 3 ′ - utr in both human and mouse cell lines ( 54 - 56 ). the aforementioned mir - 29, as well as other mirnas that directly target bace1 in vitro, such as mir -',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_2',\n",
       "  'chunk_index': 2,\n",
       "  'text': 'bace1 expression by targeting the 3 ′ - utr in both human and mouse cell lines ( 54 - 56 ). the aforementioned mir - 29, as well as other mirnas that directly target bace1 in vitro, such as mir - 298 / 328 ( 57 ), mir - 135a, mir - 135b ( 59 ), mir - 9 ( 60 ), mir - 298, mir - 339 - 5p, mir - 195 ( 61 ) and mir - 107 ( 62 ), are deregulated in brains affected by ad, mainly exhibited a reduced expression ( 36, 63 ). mir - 9 is another mirna involved in aβ regulation, targeting calcium / calmodulin - dependent protein kinase kinase 2 ( camkk2 ), thereby attenuating aβ - induced synaptic toxicity ( 64 ). in addition, this mirna appears to be involved in insulin signaling, which may be associated with an increased risk of developing diabetes in patients with ad ( 65 ). the mir - 144 / mir - 451, finally, has been shown to regulate α - secretase adam10, which protects the brain from the production of aβ ( 66 ). the search and discovery of specialized and effective biomarkers for the prediction and early detection of ad is of utmost importance for the better management of symptoms and timely intervention ( 67, 68 ). for this purpose, mirnas have been proposed as promising candidate biomarkers due to their high stability under storage and handling conditions ( 69 ). through qpcr and rna - seq studies, it has now become possible to identify circulating mirnas in plasma and csf that serve as biomarkers for ad and to construct mirna catalogs that are differentially expressed between ad and control groups to identify new biomarkers ( 70 ). two mirnas that have been identified as suitable biomarkers for ad are mir - 181c ( 71, 72 ) and mir - 146a ( 73 -',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_3',\n",
       "  'chunk_index': 3,\n",
       "  'text': \"differentially expressed between ad and control groups to identify new biomarkers ( 70 ). two mirnas that have been identified as suitable biomarkers for ad are mir - 181c ( 71, 72 ) and mir - 146a ( 73 - 75 ). the former was found to be downregulated in the serum and csf of patients with ad, while the latter was found to be upregulated in brains affected by ad, as well as in the csf of patients with ad. mir - 455 - 3p is another potential biomarker for ad, as its level is higher in the serum of patients with ad ( 76 ), as well as mir - 485 - 3p, whose expression was found to be upregulated in patients with ad and cell models ( 77 ). circrnas are a class of non - coding rnas that originate primarily from the exonic regions of the genes encoding proteins. their length is variable, while they display significant stability. these ncrnas act as regulators of mirnas, to which they bind through specific binding sites. circrnas are expressed in central nervous system ( cns ) tissue and tend to accumulate during the normal aging process of the brain, exhibiting susceptibility to age - related neurodegenerative diseases, such as ad. this renders them potential therapeutic targets and biomarkers for the diagnosis and treatment of ad ( 78 - 80 ). a well - studied circrna that has been linked to ad is cirs - 7. this rna binds to the well - preserved mirna - 7, which is abundant in the human brain. more specifically, cirs - 7 contains several binding sites specific for mirna - 7 and acts as a ' sponge ', thus inhibiting the functions of mirna - 7 ( 81 ). in the hippocampus of patients with ad, there is a downregulation of cirs - 7 and\",\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_4',\n",
       "  'chunk_index': 4,\n",
       "  'text': \"mirna - 7 and acts as a ' sponge ', thus inhibiting the functions of mirna - 7 ( 81 ). in the hippocampus of patients with ad, there is a downregulation of cirs - 7 and, consequently, of its activity as a mirna - 7 sponge, causing the latter to exhibit increased endogenous levels in ad ( 71, 82 ). the upregulation of mirna - 7 has the ability to target and downregulate ubiquitin protein ligase, ube2a, which is involved in the autophagic clearance of amyloid peptides in the brain affected by ad ( 83 ). in addition, additional studies have reported two other circrnas that are dysregulated in cortical areas in ad, namely circhomer1 and circcoro1c. these ncrnas are significantly associated with the neuropathological status of ad, as they bind two mirnas, mir - 651 and mir - 105, respectively, which target both app and snca42 and are associated with the pathology of ad ( 63, 84 ). circrna kiaa1586 is another circrna that functions as a mirna sponge, which specifically binds several mirnas, including mir - 29b, mir - 101 and mir - 15a, that regulate different ad - associated genes ( 63, 85 ). moreover, circhdac9 binds mir - 138 and its expression is decreased in ad, resulting in the downregulation of adam10 by mir - 138, thus promoting aβ production ( 63, 86 ). in this context, circrna _ 0000950 functions as a mir - 103 sponge, leading to the upregulation of the prostaglandin - endoperoxide synthase 2 and interleukin ( il ) - 6 and il - 1β, as well as tumor nec\",\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_5',\n",
       "  'chunk_index': 5,\n",
       "  'text': \"functions as a mir - 103 sponge, leading to the upregulation of the prostaglandin - endoperoxide synthase 2 and interleukin ( il ) - 6 and il - 1β, as well as tumor necrosis factor ( tnf ), and results in an increase in neuronal cell apoptosis ( 63, 87 ). circnf1 - 419 is related to early neuropathological changes and interacts with dynamin - 1 and adaptor protein 2 b1. its overexpression reduces the levels of ad marker proteins, such as tau, p - tau, aβ1 - 42 and apoe, and inflammatory factors, including tnf and the nuclear factor kappa b subunit 1, resulting in delayed senile dementia and ad progression ( 63, 88, 89 ). it is therefore clear that circrnas may play a critical role in ad, mainly as mirna sponges ( 63 ), where the inhibition of ' sponging mirna activity ', which translates to the upregulation of specific mirnas, is a possible reason for the downregulation of important genes associated with the brain in ad ( 83 ). pirnas are also a class of ncrnas that are ~ 24 - 34 nucleotides in length and are associated with ad, as they are involved in cns stress and physical damage response. these ncrnas interact with a specific family of argonaute - associated ' mili / miwi ' rna - binding proteins and can affect the cytoplasmic translation of mrnas into proteins, as well as the transcription of genes by influencing histones and the methylation of dna ( 17 ). in general, pirnas appear to be overexpressed in neurodegenerative diseases ( 90 ). in the study by qiu et al ( 91 ), 9, 453 pirnas were detected in the brains\",\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_6',\n",
       "  'chunk_index': 6,\n",
       "  'text': '17 ). in general, pirnas appear to be overexpressed in neurodegenerative diseases ( 90 ). in the study by qiu et al ( 91 ), 9, 453 pirnas were detected in the brains of patients with ad, and 103 pirnas were associated with the risk of developing ad, of which 81 were upregulated and 22 were downregulated. pirnas are considered a potential biomarker for ad due to their association with snps of genome - wide significant risk, such as apoe ( 91 ). in addition, in the study by roy et al ( 92 ), 146 pirnas were found to be upregulated in patients with ad, while they were associated with five critical ad - related pathway targets. more specifically, the enrichment of the cycs, lin7c, kpna6 and rab11a genes was observed, regulated by four pirnas, pir - 38240, pir - 34393, pir - 40666 and pir - 51810 ( 92 ). finally, the analysis of two different ad datasets led to the identification of 10 overlapping, differentially expressed pirnas, with potential as biomarkers for ad. these pirnas include pir - hsa - 1282, pir - hsa - 23538, pir - hsa - 23566, pir - hsa - 27400, pir - hsa - 27725, pir - hsa - 28116, pir - hsa - 28189, pir - hsa - 28390, pir - hsa - 29114 and pir - hsa - 7193 ( 92 ). lncrnas are another class of ncrnas that has attracted scientific interest in the battle against neurodegenerative diseases. they are > 200 nucleotides in length',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_7',\n",
       "  'chunk_index': 7,\n",
       "  'text': 'pir - hsa - 7193 ( 92 ). lncrnas are another class of ncrnas that has attracted scientific interest in the battle against neurodegenerative diseases. they are > 200 nucleotides in length and can be derived from different regions of the genome, such as promoters, enhancers, introns, utrs, overlapping or non - coding isoforms of coding genes, antisense ( as ) to other transcripts and pseudogenes ( 93, 94 ). through technological advances and new laboratory techniques, a vast amount of information has been collected on the role of lncrnas in a variety of vital biological processes ( 95 ), including transcription ( 96 ), alternative splicing ( 97 ), translation, apoptosis ( 98 ) and the cell cycle ( 99 ). rna sequencing methods have enabled the study of lncrnas and their role in various diseases, including ad. in general, the majority of examples of lncrnas whose activity has been studied belong to the subcategory of as lncrnas. a well - studied lncrna with an elucidated involvement in ad is lncrna bace1 - as ( 100 ), which is transcribed from the complementary strand of the bace1 gene. this lncrna is in direct involvement with elevated levels of aβ 1 - 42 in ad, as it drives the feed - forward regulation of β - secretase ( 63, 101, 102 ), and it can bind to mir - 214 - 3p, promoting autophagy - mediated neuronal damage through the mir - 214 - 3p / atg5 signaling axis in ad ( 103 ). in addition to bace1 - as lncrna, nat - rad18 ( 104, 105 ) and 51a ( 63, 105, 106 ) are two other lncrnas involved in ad, as the former has been shown to be',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_8',\n",
       "  'chunk_index': 8,\n",
       "  'text': 'addition to bace1 - as lncrna, nat - rad18 ( 104, 105 ) and 51a ( 63, 105, 106 ) are two other lncrnas involved in ad, as the former has been shown to be upregulated in rat neurons in response to the aβ peptide, and the latter affects the formation of aβ and is upregulated in ad by overlapping it with sorl1. 17a is another as lncrna, which is complementary to an endogenous region of the gaba receptor gene. the expression of this lncrna leads to the production of alternative splicing transcripts of this receptor which, in combination with its upregulation in ad, leads to increased aβ secretion in neuroblastoma cells ( 107 ). according to the study by zhang and wang ( 108 ), the expression of magi2 - as3 lncrna was increased in ad cell models. this lncrna is a regulator of cell viability in diverse diseases. its overexpression enhances the effects of aβ25 - 35 on neuronal viability and neuroinflammation, and its knockdown reduces neurotoxicity and neuroinflammation, highlighting the potential role of magi2 - as3 in ad progression and treatment. moreover, this lncrna functions as an mir - 374b - 5p sponge, a mirna that targets bace1 mrna and interacts with akt1, reck, wnt16, vegfa, tacc1 and srsf7 mrnas, and with compounds including cisplatin, gemcitabine, tamoxifen and 5 - fluorouracil ( 108 ). long intergenic ncrnas ( lincrnas ) are another subcategory of lncrnas that are abundant in the human genome. the primate - specific bc200 rna',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_9',\n",
       "  'chunk_index': 9,\n",
       "  'text': '##n and 5 - fluorouracil ( 108 ). long intergenic ncrnas ( lincrnas ) are another subcategory of lncrnas that are abundant in the human genome. the primate - specific bc200 rna ( bcyrn1 ) is a lincrna that may be involved in ad. this rna was detected in the dendritic domains of neurons and its downregulation was observed during aging ( 63, 105, 109 ). the critical role of lncrnas in ad was first evidenced through the study of zhou and xu ( 110 ), which used an algorithm to analyze microarray data from the brain and identified ~ 100 lncrnas that were altered in ad. notably, a number of these lncrnas were specific to the brain and could be used as biomarkers for ad, since altered expression signatures of lncrnas provided the ability to predict ad with the same accuracy as the altered protein - coding genes, while requiring fewer lncrnas for optimal prediction in comparison to protein - coding genes ( 110 ). in addition, in a study by magistri et al ( 111 ), significant alterations in the lncrna expression profile were observed in brains affected by ad, with the majority of the altered lncrnas found to be intergenic. according to the results of that study, the as lncrnas, ad - linc2, hao2 - as and ebf3 - as were dependent on neuronal activity, while ad - linc1 was upregulated in response to aβ ( 111 ). these efforts are only the beginning of a long road toward the complete elucidation of the involvement of lncrnas in ad, with further studies required to explore their potential as novel biomarkers and pharmacological targets. in summary, the main ncrnas that are involved in ad are classified into four categories, mir',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_10',\n",
       "  'chunk_index': 10,\n",
       "  'text': \"the involvement of lncrnas in ad, with further studies required to explore their potential as novel biomarkers and pharmacological targets. in summary, the main ncrnas that are involved in ad are classified into four categories, mirnas, pirnas, circrnas and lncrnas. these non - coding molecules function via several mechanisms, such as inhibiting or promoting the expression of genes that are associated with ad, or they can be used as effective biomarkers as their expression is altered in ad - affected brains. these two types of classification of those ncrnas, based on their category and based on their function, are illustrated in fig. 1. the wave of ' omics ' has been taking the scientific world by storm, encompassing genomics, transcriptomics, epigenomics, proteomics, metabolomics and lipidomics as part of a rounded approach ( 112 ). when faced with complex diseases, such as ad, the efficient analysis and integration of data that omics technologies yield is critical for the development of diagnostics and therapeutics ( 28, 113, 114 ). genetics studies, genome - wide association studies ( gwas ) and next - generation sequencing ( ngs ) technologies have helped to gain knowledge about the genes which are associated with a risk of developing ad. genetic studies have enabled the detection of rare mutations in the genes of app, psen1 and psen2, which are associated with the dominantly inherited early - onset ad, as well as the identification of genetic components that affect the development of the sporadic cases of the disease. in addition, genomics analysis has shown that gene - gene interaction can be a significant risk factor for the development of ad ( 115, 116 ). gwas can lead to the identification of genes with common variants involved in various diseases. by comparing the whole genome set of genetic variants in different individuals, gwas shed light on snp characteristics of different diseases, highlighting the\",\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_11',\n",
       "  'chunk_index': 11,\n",
       "  'text': '( 115, 116 ). gwas can lead to the identification of genes with common variants involved in various diseases. by comparing the whole genome set of genetic variants in different individuals, gwas shed light on snp characteristics of different diseases, highlighting the possibility of associations between the detected variants. several genomic loci of interest have been identified that may increase the risk of an individual for developing late - onset ad, including genes involved in β - amyloid processing and clearance, immune response and inflammation, such as cr1, cd33, ms4a, abca7 epha1 and mef2c, in the metabolism of cholesterol, such as apoe, sorl1, abca7 and clu, and in the regulation of endocytosis, such as bin1, cd2ap, picalm, epha1, sorl1 ( 117, 118 ). in addition to gwas, ngs technologies, including whole genome sequencing and whole exome sequencing, enable the detection of rare mutations that affect complex diseases. significant are the findings of ngs studies, which have identified new risk genes with low - frequency variants, including trem2, which encodes the adam10 activation receptor expressed in myeloid cells and leads to defective α - secretory activity, phospholipase d3, unc5c and akap9 ( 119, 120 ). non - hereditary epigenetic changes have the potential to equally affect the risk of developing ad. epigenetic modifications mainly involve dna methylation and histone modification, thereby regulating gene expression. in the case of ad, the reduced methylation of dna is described, while at the same time, a number of genes that have been characterized in ad exhibit a high level of methylation in their promoters and in the cytosines that precede guanines ( cpg islands ) ( 121 ). two large - scale epigenome - wide association studies have',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_12',\n",
       "  'chunk_index': 12,\n",
       "  'text': 'genes that have been characterized in ad exhibit a high level of methylation in their promoters and in the cytosines that precede guanines ( cpg islands ) ( 121 ). two large - scale epigenome - wide association studies have identified four new genetic loci, including rhbdf2, rpl13, c10orf54 - cdh23 and ank1, with differential methylation, suggesting an association with the risk of developing ad ( 122, 123 ). however, histone modification studies have yielded conflicting results regarding histone acetylation levels in ad ( 124 - 127 ). thus, the heterogeneity of results from epigenomics studies indicates that the further evaluation of epigenomics alterations is necessary, reflecting both changes in cell composition and cell - specific changes associated with ad pathology. transcriptome analysis provides the ability to evaluate the number of transcripts that result through alternative splicing, novel transcript identification and long and small ncrnas. several studies have highlighted the critical role of ncrnas, mostly focusing on the role of mirnas in ad ( 68, 128 - 130 ). as aforementioned, mirna profiles can be investigated in several biological fluids, including blood and csf ( 131 ), as several ad - related mirnas have been identified following an analysis of brain tissue in patients with ad ( 132 ). the analysis of circulating mirnas is very promising for the study of the pathogenesis of ad ; however, the heterogeneity of the research results requires the participation of a greater number of patients for the study of the transcriptome. proteomics studies provide the ability to discover and record potential biomarkers and validate potential candidate proteins in various diseases. furthermore, mass spectrometry ( ms ) offers effective capabilities in the analysis and determination of proteins in combination with chromatographic or other separation techniques ( 133 ). through a standard proteomics platform, which includes two - dimensional',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_13',\n",
       "  'chunk_index': 13,\n",
       "  'text': 'diseases. furthermore, mass spectrometry ( ms ) offers effective capabilities in the analysis and determination of proteins in combination with chromatographic or other separation techniques ( 133 ). through a standard proteomics platform, which includes two - dimensional gel electrophoresis in combination with ms, novel candidate biomarkers were identified in the biological fluids of patients with ad, primarily involved in the processing pathway of the aβ peptide ( 134, 135 ). additionally, proteomics studies have identified eight protein biomarkers among 100 candidates, the levels of which tend to decrease in cases of ad ( 136 ). a notable finding of extensive target proteomics studies is the presence of different isoforms of aβ peptides, which arise through alternative pathways of app degradation, identifying the isoforms aβ42, aβ40 and aβ38, as well as appα and appβ in csf and brain tissue samples from patients with ad ( 137 - 139 ). in addition, a significant increase in neurogranin levels in csf was evidenced in patients with ad ( 140 ), in contrast to a significant decrease in apoe levels in the serum of patients with ad ( 141 ). through a proteomics study, the interaction of brain transglutaminase interaction with app, huntingtin and α - synuclein was observed, thus demonstrating the role of brain transglutaminase in the formation of protein aggregates in various neurodegenerative diseases ( 142 ). in addition, oxidatively modified proteins associated with tau and aβ pathology have been identified in the brains of patients with ad through redox proteomics studies ( 143 ). lastly, the study by chiasserini et al ( 144 ) yielded information on 1, 315 proteins, including neurodegenerative disease biomarkers such as app, prion protein and dj - 1. metabolomics studies examine and focus on metabolites, which are small molecules',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_14',\n",
       "  'chunk_index': 14,\n",
       "  'text': 'al ( 144 ) yielded information on 1, 315 proteins, including neurodegenerative disease biomarkers such as app, prion protein and dj - 1. metabolomics studies examine and focus on metabolites, which are small molecules ( < 1, 500 da ) that are involved in numerous biological functions and vary as a result of genetic, transcriptional and protein changes, as well as environmental influences. the main techniques used in metabolomics studies are ms and nuclear magnetic resonance spectroscopy ( 28 ). significant alterations in the abundance of metabolites in the biological fluids of patients with ad have been observed. according to a previous study, a change in eight metabolites was detected, including acylcarnitine, sphingomyelins and glycerophospholipids, which were significantly increased in the csf of patients ( 145 ). furthermore, the quantitative analysis of 17 metabolites led to the observation of a significant increase in glycine and s - adenosylhomocysteine levels, with a concomitant decrease in the levels of s - adenosylmethionine in the csf of patients diagnosed with ad ( 146 ). similarly, shifts of 13 key metabolites were recorded at different stages of ad by researchers at the alzheimer disease metabolomics consortium, exhibiting associations with the csf aβ42 and t - tau / aβ42 ratio, with cognitive function or brain atrophy ( 147 ). finally, through two previous studies, 10 and 24 plasma lipids were detected to predict the conversion of healthy individuals to patients with ad ( 148, 149 ). the development and analysis of a wealth of big data have been accompanied by advances in bioinformatics and computational programming ( 150, 151 ). an example of a large - scale omics platform for ad is the dominantly inherited alzheimer network ( dian ) central archive ( https : / / dian. wust',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_15',\n",
       "  'chunk_index': 15,\n",
       "  'text': 'advances in bioinformatics and computational programming ( 150, 151 ). an example of a large - scale omics platform for ad is the dominantly inherited alzheimer network ( dian ) central archive ( https : / / dian. wustl. edu / ), which provides all the cognitive information, biomarkers and brain imaging information for ad, while allowing the data analysis of different domains and wide access to them ( 28 ). the analysis and interpretation of big data are one of the most important issues of concern to the scientific community, with the main goal of analyzing the cross - platform association between data from different omics technologies. furthermore, computational biology pipelines can aid the development of antibody - interacting drugs against neurodegenerative diseases, such as ad, a rapidly emerging field of increasing medicinal interest ( 152 ). big data allow for rapid advances in personalized medicine ; however, the heterogeneity and variability of omics data hinder the application of omics science ( 28 ). alterations in genomics, proteomics, epigenomics, transcriptomics, metabolomics and lipidomic levels may be associated with the development of neurodegenerative diseases, such as ad, worldwide. the development of computational tools for big data analysis based on phenotypic analytical prediction models remains a challenge for de novo drug design or effective drug repurposing ( 28 ). deep learning methods can provide a potential solution to this challenge, allowing the exploitation of multi - omics data and helping to form an accurate representation of ad patients. this approach can allow researchers to develop effective personalized treatments and early diagnostic tools, as well as guide the design or repurposing of drugs in complex neurodegenerative pathologies ( 153 ). an integrative multi - omics approach, as previously described by clark et al ( 154 ), yielded promising results, identifying novel molecular and pathway alterations which are related to the pathophy',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_16',\n",
       "  'chunk_index': 16,\n",
       "  'text': 'neurodegenerative pathologies ( 153 ). an integrative multi - omics approach, as previously described by clark et al ( 154 ), yielded promising results, identifying novel molecular and pathway alterations which are related to the pathophysiological processes of ad. a notable strength of this approach is the identification of the main axes of inter - individual heterogeneity, critical for the development of tailored therapeutic interventions ( 154 ). ad is a multifactorial disease, which in addition to the genetic and hereditary background, also occurs sporadically, due to epigenetic factors, which include ncrnas. these molecules are implicated in a wide range of cellular processes and human diseases, including neurodegeneration. several studies at various levels, including the molecular, cellular, physiological and epidemiological ones, have detected a rising number of ncrnas involved in ad. as aforementioned, they participate in the three major pathogenic traits of ad that include the formation of aβ plaques, the phosphorylation of tau, and the establishments of an inflammatory zone. in order to identify these ncrnas, various studies have examined both cultured cell models and biological samples, such as brain, csf and serum. in this context, their identification can be managed using sensitive methods of rna analysis, including reverse transcription followed by conventional pcr or qpcr analyses for the survey of individual rnas, or rna - sequencing and analysis by microarray for the survey of larger panels of rnas. these methods would be particularly useful if the diagnostic and prognostic ncrnas were tested in tissues and fluids easily accessible, such as blood, urine and some epithelia ( 129 ). in conjunction with these non - coding biomarkers, omics technologies are a promising tool for the study of ad pathology and patient variation, providing the ability to combine and correlate different types of data, the analysis of which could lead to personal',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'},\n",
       " {'id': 'PMC9747195::chunk_17',\n",
       "  'chunk_index': 17,\n",
       "  'text': 'in conjunction with these non - coding biomarkers, omics technologies are a promising tool for the study of ad pathology and patient variation, providing the ability to combine and correlate different types of data, the analysis of which could lead to personalized therapy and de novo development of more effective drugs. the integration of omics and clinical data and the development of novel experimental and computational strategies are essential in multifactorial diseases, such as ad. in these cases, high - throughput omics technologies can lead to the better understanding of the pathological changes in the brain, to the development of more accurate tools for the early diagnosis and prediction of the disease, to the development of new drugs, as well to the selection of the most beneficial and personalized therapies.',\n",
       "  'title': \"Role of non-coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)\",\n",
       "  'pub_date': '2022-11-24',\n",
       "  'doi': '10.3892/ijmm.2022.5208'}]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "04336f82",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"alzheimer ' s disease ( ad ), the most common form of dementia, is a central neurodegenerative disease characterized by progressive cognitive impairment and memory loss. the main pathological features include intracellular neurofibrillary tangles ( 1 ) and extracellular β - amyloid ( aβ ) peptide aggregation ( 2 ) to form senile plaques. these pathological changes lead to clinical manifestations characterized by memory loss, impairment of abstract thinking, numeracy deficits, and changes in personality and behavior ( 3 ). according to previous studies, the pathogenesis of ad mainly includes the following : abnormal accumulation of aβ ( 4 ), τ - protein hyperphosphorylation ( 5 ), neuroinflammation ( 6 ), cardiocerebral cascade ( 7 ), cholinergic deficiency ( 8 ), excitatory amino acid toxicity ( 9 ). at present, there is no treatment to cure or delay the process of the disease. however, with the increasing number of patients with ad, ad has become one of the main medical and health societal issues. to address the lack of effective drugs and the failure of continuous clinical trials, the current research focus is on therapeutic strategies for inducing the regeneration of neural stem cells ( nscs ). in recent years, research on promoting targeted neural regeneration has received increasing attention. therefore, the current review is focused on the mechanisms of induced nerve regeneration in the treatment of ad. neural regeneration is the process of generating new neurons or restoring neuronal structure, which mainly refers to the proliferation and differentiation of neural progenitor cells, and the synaptic plasticity of neurons against memory disorders and the ageing - related decline of learning and memory ( 10 ). in 1965, altman and das ( 11 ) first demonstrated that new neurons could be generated in the adult mammalian brain. since then, continuous studies have found that nerve regeneration in the brains of adult mammals mainly occurs in two regions, namely\""
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results[0]['text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "79839238",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'10 ). in 1965, altman and das ( 11 ) first demonstrated that new neurons could be generated in the adult mammalian brain. since then, continuous studies have found that nerve regeneration in the brains of adult mammals mainly occurs in two regions, namely, the subgranular zone in the dentate gyrus of the hippocampus and the subventricular zone ( 12, 13 ). nerve regeneration may also occur in other brain areas, such as the neocortex ( 14 ) and striatum ( 15 ). however, neurogenesis in these areas seems to occur at lower levels. to explore whether neurogenesis in humans lasts a lifetime, tobin et al ( 16 ) examined the brains of 18 cadaver donors with a mean age of 90. 6 years in 2019. among them, not only proliferating neural precursor cells ( nestin + / pcna + ), undifferentiated neural stem cells ( nestin + sox2 + ) and proliferating neural stem cells ( nestin + / sox2 + / ki67 + ), but also newborn immature neurons [ doublecortin ( dcx ) + / pcna + ], were found in the brains of patients with ad, which indicated that hippocampal neurogenesis persisted in the aged and diseased human brain ( 16 ). in addition, the study found a clear association between the number of newborn immature neurons and the cognitive scores of these donors. the more dcx + / pcna + cells that are produced, the more cognitive performance is improved, suggesting that the number of neurons is positively associated with cognitive function ( 16 ). the level of cognitive function also depends to some extent on the integrity and transmission efficiency of synapses. synapses are the sites where functional connections form between neurons, and they are also the key places for information transmission. synapses are structurally unstable and dynamic, which can mean that they are susceptible to nutrient'"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "results[1]['text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "61e7c865",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "rag-env",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.13"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
